{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:28:38Z","timestamp":1761060518641,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4107-1","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T03:26:03Z","timestamp":1518837963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Oxidative damage and response to Bacillus Calmette-Gu\u00e9rin in bladder cancer cells expressing sialyltransferase ST3GAL1"],"prefix":"10.1186","volume":"18","author":[{"given":"Paulo F.","family":"Severino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mylene","family":"Carrascal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Malagolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariella","family":"Chiricolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Venturi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Barbaro Forleo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Astolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Catera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula A.","family":"Videira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9384-2845","authenticated-orcid":false,"given":"Fabio","family":"Dall\u2019Olio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"issue":"4","key":"4107_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","volume":"91","author":"RF Bevers","year":"2004","unstructured":"Bevers RF, Kurth KH, Schamhart DH. Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br J Cancer. 2004;91(4):607\u201312.","journal-title":"Br J Cancer"},{"issue":"4","key":"4107_CR2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.urology.2009.02.053","volume":"74","author":"PA Videira","year":"2009","unstructured":"Videira PA, Calais FM, Correia M, Ligeiro D, Crespo HJ, Calais F, Trindade H. Efficacy of bacille Calmette-Guerin immunotherapy predicted by expression of antigen-presenting molecules and chemokines. Urology. 2009;74(4):944\u201350.","journal-title":"Urology"},{"issue":"4","key":"4107_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/ijc.25733","volume":"129","author":"R Carretero","year":"2011","unstructured":"Carretero R, Cabrera T, Gil H, Saenz-Lopez P, Maleno I, Aptsiauri N, Cozar JM, Garrido F. Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells. Int J Cancer. 2011;129(4):839\u201346.","journal-title":"Int J Cancer"},{"key":"4107_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2741\/3951","volume":"17","author":"F Dall'Olio","year":"2012","unstructured":"Dall'Olio F, Malagolini N, Trinchera M, Chiricolo M. Mechanisms of cancer-associated glycosylation changes. Front Biosci. 2012;17:670\u201399.","journal-title":"Front Biosci"},{"issue":"4","key":"4107_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10147-008-0809-8","volume":"13","author":"C Ohyama","year":"2008","unstructured":"Ohyama C. Glycosylation in bladder cancer. Int J Clin Oncol. 2008;13(4):308\u201313.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"4107_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1021\/pr5006026","volume":"14","author":"G Yang","year":"2015","unstructured":"Yang G, Tan Z, Lu W, Guo J, Yu H, Yu J, Sun C, Qi X, Li Z, Guan F. Quantitative Glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy. J Proteome Res. 2015;14(2):639\u201353.","journal-title":"J Proteome Res"},{"issue":"3","key":"4107_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molonc.2013.03.001","volume":"7","author":"JA Ferreira","year":"2013","unstructured":"Ferreira JA, Videira PA, Lima L, Pereira S, Silva M, Carrascal M, Severino PF, Fernandes E, Almeida A, Costa C, et al. Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours. Mol Oncol. 2013;7(3):719\u201331.","journal-title":"Mol Oncol"},{"issue":"8","key":"4107_CR8","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1038\/bjc.2013.571","volume":"109","author":"L Lima","year":"2013","unstructured":"Lima L, Severino PF, Silva M, Miranda A, Tavares A, Pereira S, Fernandes E, Cruz R, Amaro T, Reis CA, et al. Response of high-risk of recurrence\/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy. Br J Cancer. 2013;109(8):2106\u201314.","journal-title":"Br J Cancer"},{"issue":"1","key":"4107_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0304-4165(99)00170-1","volume":"1473","author":"I Brockhausen","year":"1999","unstructured":"Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta. 1999;1473(1):67\u201395.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"4107_CR10","first-page":"4851","volume":"61","author":"VV Glinsky","year":"2001","unstructured":"Glinsky VV, Glinsky GV, Rittenhouse-Olson K, Huflejt ME, Glinskii OV, Deutscher SL, Quinn TP. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res. 2001;61(12):4851\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"4107_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1476-4598-9-154","volume":"9","author":"Q Zhao","year":"2010","unstructured":"Zhao Q, Barclay M, Hilkens J, Guo X, Barrow H, Rhodes JM, Yu LG. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol Cancer. 2010;9(1):154.","journal-title":"Mol Cancer"},{"issue":"10","key":"4107_CR12","first-page":"2584","volume":"60","author":"VV Glinsky","year":"2000","unstructured":"Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on \u03b2-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res. 2000;60(10):2584\u20138.","journal-title":"Cancer Res"},{"issue":"4","key":"4107_CR13","first-page":"507","volume":"27","author":"V Engelstaedter","year":"2012","unstructured":"Engelstaedter V, Fluegel B, Kunze S, Mayr D, Friese K, Jeschke U, Bergauer F. Expression of the carbohydrate tumour marker Sialyl Lewis a, Sialyl Lewis X, Lewis Y and Thomsen-Friedenreich antigen in normal squamous epithelium of the uterine cervix, cervical dysplasia and cervical cancer. Histol Histopathol. 2012;27(4):507\u201314.","journal-title":"Histol Histopathol"},{"key":"4107_CR14","first-page":"840","volume":"4","author":"A Almogren","year":"2012","unstructured":"Almogren A, Abdullah J, Ghapure K, Ferguson K, Glinsky VV, Rittenhouse-Olson K. Anti-Thomsen-Friedenreich-ag (anti-TF-ag) potential for cancer therapy. Front Biosci (Schol Ed). 2012;4:840\u201363.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"3","key":"4107_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2217\/fon.13.209","volume":"10","author":"K Ferguson","year":"2014","unstructured":"Ferguson K, Yadav A, Morey S, Abdullah J, Hrysenko G, Eng JY, Sajjad M, Koury S, Rittenhouse-Olson K. Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer. Future Oncol. 2014;10(3):385\u201399.","journal-title":"Future Oncol"},{"issue":"11","key":"4107_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1593\/neo.06493","volume":"8","author":"J Heimburg","year":"2006","unstructured":"Heimburg J, Yan J, Morey S, Glinskii OV, Huxley VH, Wild L, Klick R, Roy R, Glinsky VV, Rittenhouse-Olson K. Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia. 2006;8(11):939\u201348.","journal-title":"Neoplasia"},{"issue":"2","key":"4107_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1432-1033.1995.607_2.x","volume":"233","author":"I Brockhausen","year":"1995","unstructured":"Brockhausen I, Yang JM, Burchell J, Whitehouse C, Taylor-Papadimitriou J. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem. 1995;233(2):607\u201317.","journal-title":"Eur J Biochem"},{"issue":"6","key":"4107_CR18","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1083\/jcb.137.6.1229","volume":"137","author":"C Whitehouse","year":"1997","unstructured":"Whitehouse C, Burchell J, Gschmeissner S, Brockhausen I, Lloyd KO, Taylor-Papadimitriou J. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial\/trans-Golgi apparatus inhibits the development of core-2-based O-glycans. J Cell Biol. 1997;137(6):1229\u201341.","journal-title":"J Cell Biol"},{"issue":"11\u201312","key":"4107_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1023\/A:1022288022969","volume":"18","author":"F Dall'Olio","year":"2001","unstructured":"Dall'Olio F, Chiricolo M. Sialyltransferases in cancer. Glycoconj J. 2001;18(11\u201312):841\u201350.","journal-title":"Glycoconj J"},{"issue":"9","key":"4107_CR20","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.bbagen.2014.06.006","volume":"1840","author":"F Dall'Olio","year":"2014","unstructured":"Dall'Olio F, Malagolini N, Trinchera M, Chiricolo M. Sialosignaling: Sialyltransferases as engines of self-fueling loops in cancer progression. Biochim Biophys Acta. 2014;1840(9):2752\u201364.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4107_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/1097-0142(19920101)69:1<219::AID-CNCR2820690136>3.0.CO;2-A","volume":"69","author":"NC Langkilde","year":"1992","unstructured":"Langkilde NC, Wolf H, Clausen H, Kjeldsen T, Orntoft TF. Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn- antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression. Cancer. 1992;69(1):219\u201327.","journal-title":"Cancer"},{"key":"4107_CR22","first-page":"45","volume":"172","author":"NC Langkilde","year":"1995","unstructured":"Langkilde NC. T-Antigens in primary non-invasive and superficially invasive human urinary bladder tumors: the correlation to tumor recurrence and tumor progression. A mini-review. Scand J Urol Nephrol Suppl. 1995;172:45\u20139.","journal-title":"Scand J Urol Nephrol Suppl"},{"issue":"4","key":"4107_CR23","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0022-5347(17)38959-0","volume":"142","author":"JA Dow","year":"1989","unstructured":"Dow JA, di Sant'Agnese PA, Cockett AT. Expression of blood group precursor T antigen as a prognostic marker for human bladder cancer treated by bacillus Calmette-Guerin and interleukin-2. J Urol. 1989;142(4):978\u201381.","journal-title":"J Urol"},{"issue":"1","key":"4107_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/1471-2407-9-357","volume":"9","author":"PA Videira","year":"2009","unstructured":"Videira PA, Correia M, Malagolini N, Crespo HJ, Ligeiro D, Calais FM, Trindade H, Dall'Olio F. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines. BMC Cancer. 2009;9(1):357.","journal-title":"BMC Cancer"},{"issue":"4","key":"4107_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jnci\/58.4.881","volume":"58","author":"S Rasheed","year":"1977","unstructured":"Rasheed S, Gardner MB, Rongey RW, Nelson-Rees WA, Arnstein P. Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J Natl Cancer Inst. 1977;58(4):881\u201390.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"4107_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molonc.2014.02.008","volume":"8","author":"MA Carrascal","year":"2014","unstructured":"Carrascal MA, Severino PF, Guadalupe CM, Silva M, Ferreira JA, Calais F, Quinto H, Pen C, Ligeiro D, Santos LL, et al. Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells. Mol Oncol. 2014;8(3):753\u201365.","journal-title":"Mol Oncol"},{"issue":"1 Suppl","key":"4107_CR27","volume":"128","author":"HJ Crespo","year":"2009","unstructured":"Crespo HJ, Cabral MG, Teixeira AV, Lau JT, Trindade H, Videira PA. Effect of sialic acid loss on dendritic cell maturation. Immunology. 2009;128(1 Suppl):e621-e631.","journal-title":"Immunology"},{"issue":"2","key":"4107_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1525-1578(10)60652-6","volume":"3","author":"J Meijerink","year":"2001","unstructured":"Meijerink J, Mandigers C, van de Locht L, Tonnissen E, Goodsaid F, Raemaekers J. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. J Mol Diagn. 2001;3(2):55\u201361.","journal-title":"J Mol Diagn"},{"issue":"1","key":"4107_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem. 1987;162(1):156\u20139.","journal-title":"Anal Biochem"},{"issue":"10","key":"4107_CR30","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/glycob\/cwq085","volume":"20","author":"G Picco","year":"2010","unstructured":"Picco G, Julien S, Brockhausen I, Beatson R, Antonopoulos A, Haslam S, Mandel U, Dell A, Pinder S, Taylor-Papadimitriou J, et al. Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology. 2010;20(10):1241\u201350.","journal-title":"Glycobiology"},{"issue":"53","key":"4107_CR31","doi-asserted-by":"publisher","first-page":"44490","DOI":"10.1074\/jbc.M112.425827","volume":"287","author":"D Sproviero","year":"2012","unstructured":"Sproviero D, Julien S, Burford B, Taylor-Papadimitriou J, Burchell JM. Cyclooxygenase-2 enzyme induces the expression of the \u03b1-2,3-Sialyltransferase-3 (ST3Gal-I) in breast cancer. J Biol Chem. 2012;287(53):44490\u20137.","journal-title":"J Biol Chem"},{"issue":"6","key":"4107_CR32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/002215540305100607","volume":"51","author":"NT Marcos","year":"2003","unstructured":"Marcos NT, Cruz A, Silva F, Almeida R, David L, Mandel U, Clausen H, Mensdorff-Pouilly S, Reis CA. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal- transferase I expression in gastric carcinoma cell lines. J Histochem Cytochem. 2003;51(6):761\u201371.","journal-title":"J Histochem Cytochem"},{"issue":"6 Pt 2","key":"4107_CR33","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/trf.12981","volume":"55","author":"d Burin","year":"2015","unstructured":"Burin d, Roziers N, Chadebech P, Bodivit G, Guinchard E, Bruneel A, Dupre T, Chevret L, Jugie M, Gallon P, Bierling P, et al. Red blood cell Thomsen-Friedenreich antigen expression and galectin-3 plasma concentrations in Streptococcus Pneumoniae-associated hemolytic uremic syndrome and hemolytic anemia. Transfusion. 2015;55(6 Pt 2):1563\u201371.","journal-title":"Transfusion"},{"issue":"2","key":"4107_CR34","first-page":"181","volume":"9","author":"RF Bevers","year":"1998","unstructured":"Bevers RF, de Boer EC, Kurth KH, Schamhart DH. BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines. Eur Cytokine Netw. 1998;9(2):181\u20136.","journal-title":"Eur Cytokine Netw"},{"issue":"2","key":"4107_CR35","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0022-5347(05)64745-3","volume":"168","author":"FH Chen","year":"2002","unstructured":"Chen FH, Crist SA, Zhang GJ, Iwamoto Y, See WA. Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guerin through nuclear factor-kappaB and Ap-1 via an immediate early pathway. J Urol. 2002;168(2):786\u201397.","journal-title":"J Urol"},{"issue":"3","key":"4107_CR36","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/S0022-5347(05)65348-7","volume":"167","author":"B Andrews","year":"2002","unstructured":"Andrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol. 2002;167(3):1475\u201381.","journal-title":"J Urol"},{"issue":"4","key":"4107_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061901","volume":"8","author":"MF Chen","year":"2013","unstructured":"Chen MF, Lin PY, Wu CF, Chen WC, Wu CT. IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLoS One. 2013;8(4):e61901.","journal-title":"PLoS One"},{"issue":"2 Pt 1","key":"4107_CR38","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0022-5347(01)67113-1","volume":"154","author":"K Esuvaranathan","year":"1995","unstructured":"Esuvaranathan K, Alexandroff AB, McIntyre M, Jackson AM, Prescott S, Chisholm GD, James K. Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy. J Urol. 1995;154(2 Pt 1):572\u20135.","journal-title":"J Urol"},{"issue":"6","key":"4107_CR39","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1016\/j.juro.2009.08.018","volume":"182","author":"F Chen","year":"2009","unstructured":"Chen F, Zhang G, Cao Y, Hessner MJ, See WA. MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin. J Urol. 2009;182(6):2932\u20137.","journal-title":"J Urol"},{"issue":"1","key":"4107_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0090-4295(03)00134-1","volume":"62","author":"E Sheryka","year":"2003","unstructured":"Sheryka E, Wheeler MA, Hausladen DA, Weiss RM. Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma. Urology. 2003;62(1):162\u20136.","journal-title":"Urology"},{"issue":"2","key":"4107_CR41","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.3816\/CGC.2009.n.016","volume":"7","author":"L Sagnak","year":"2009","unstructured":"Sagnak L, Ersoy H, Ozok U, Senturk B, Ercil H, Bahar G, Ozturk E. Predictive value of urinary interleukin-8 cutoff point for recurrences after transurethral resection plus induction bacillus Calmette-Guerin treatment in non-muscle-invasive bladder tumors. Clin Genitourin Cancer. 2009;7(2):E16\u201323.","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"4107_CR42","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/S0022-5347(05)64361-3","volume":"168","author":"A Kumar","year":"2002","unstructured":"Kumar A, Dubey D, Bansal P, Mandhani A, Naik S. Urinary interleukin-8 predicts the response of standard and low dose intravesical bacillus Calmette-Guerin (modified Danish 1331 strain) for superficial bladder cancer. J Urol. 2002;168(5):2232\u20135.","journal-title":"J Urol"},{"issue":"3","key":"4107_CR43","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2249.1995.tb05560.x","volume":"99","author":"AM Jackson","year":"1995","unstructured":"Jackson AM, Alexandroff AB, Kelly RW, Skibinska A, Esuvaranathan K, Prescott S, Chisholm GD, James K. Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guerin (BCG) immunotherapy. Clin Exp Immunol. 1995;99(3):369\u201375.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"4107_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","volume":"7","author":"F Balkwill","year":"2005","unstructured":"Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7(3):211\u20137.","journal-title":"Cancer Cell"},{"issue":"7203","key":"4107_CR45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344.","journal-title":"Nature"},{"issue":"5","key":"4107_CR46","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3892\/ol.2016.4392","volume":"11","author":"H Takeuchi","year":"2016","unstructured":"Takeuchi H, Tanaka M, Tanaka A, Tsunemi A, Yamamoto H. Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness. Oncol Lett. 2016;11(5):3403\u20138.","journal-title":"Oncol Lett"},{"issue":"4","key":"4107_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.urolonc.2013.10.012","volume":"32","author":"L Lima","year":"2014","unstructured":"Lima L, Oliveira D, Tavares A, Amaro T, Cruz R, Oliveira MJ, Ferreira JA, Santos L. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Urol Oncol. 2014;32(4):449\u201357.","journal-title":"Urol Oncol"},{"issue":"4","key":"4107_CR48","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.juro.2014.05.115","volume":"192","author":"G Shah","year":"2014","unstructured":"Shah G, Zielonka J, Chen F, Zhang G, Cao Y, Kalyanaraman B, See W. H2O2 generation by bacillus Calmette-Guerin induces the cellular oxidative stress response required for bacillus Calmette-Guerin direct effects on urothelial carcinoma biology. J Urol. 2014;192(4):1238\u201348.","journal-title":"J Urol"},{"key":"4107_CR49","doi-asserted-by":"crossref","unstructured":"Chong YK, Sandanaraj E, Koh LW, Thangaveloo M, Tan MS, Koh GR, Toh TB, Lim GG, Holbrook JD, Kon OL, et al. ST3GAL1-associated transcriptomic program in glioblastoma tumor growth, invasion, and prognosis. J Natl Cancer Inst. 2016;108(2)","DOI":"10.1093\/jnci\/djv326"},{"issue":"4","key":"4107_CR50","first-page":"218","volume":"25","author":"AC Stanley","year":"2010","unstructured":"Stanley AC, Lacy P. Pathways for cytokine secretion. Physiology (Bethesda). 2010;25(4):218\u201329.","journal-title":"Physiology (Bethesda)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4107-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T21:31:29Z","timestamp":1550352689000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4107-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4107"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4107-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"3 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study does not use samples from diseased persons. The blood used for the preparation of monocyte-derived macrophages was from healthy blood donor voluntaries. For this, no study approval was necessary. The only authorization required was that obtained from the Blood Collection Service of the Pizzardi Hospital in Bologna, Italy, which keeps the rights on donors\u2019 blood samples. This authorization is available to the Editor.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"198"}}